Mirati Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

10.01.24	Mirati Therapeutics Receives Marketing Authorization For KRAZATI From European Commission (RTTNews)
22.12.23	Our 2023 'Short-Term Investor' Winners! Did You Ride The Rally? (RTTNews)
30.11.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MRTX, HES, SIX, MIRO (PR Newswire)
31.10.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SP, PCTI, MRTX (PR Newswire)
17.10.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CNSL, PCTI, SP, MRTX (PR Newswire)
10.10.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NWLI, MRTX, SLGC, PNT (PR Newswire)
09.10.23	Mirati Therapeutics Falls 5% After Bristol Myers Squibb Decides To Acquire It (RTTNews)
09.10.23	Bristol Myers To Acquire Mirati Therapeutics In Deal Worth Up To $5.8 Bln (RTTNews)
23.08.23	Mirati Therapeutics CFO Laurie Stelzer Resigns (RTTNews)
21.07.23	Mirati Therapeutics: CHMP Issues Negative Opinion On Conditional MAA For KRAZATI (RTTNews)
22.12.22	Pre-market Movers: ORIC, OCUP, TGS, MRTX, PARR… (RTTNews)
13.12.22	Pre-market Movers: ACMR, CNCE, MRTX, LEV, AMAM… (RTTNews)
13.12.22	QIAGEN: FDA Approves Therascreen KRAS Kit As Companion Diagnostic Test To Mirati's Drug For NSCLC (RTTNews)
13.12.22	FDA Grants Accelerated Approval For Mirati Therapeutics' Lung Cancer Drug KRAZATI (RTTNews)
13.12.22	Mirati Therapeutics Announces U.S. FDA Accelerated Approval of KRAZATI™ (adagrasib) as a Targeted Treatment Option for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCL... (PR Newswire)
28.11.22	Biotech Stocks Facing FDA Decision In December 2022 (RTTNews)
12.10.22	Mirati, Aadi To Evaluate Adagrasib, Nab-sirolimus Combination To Treat NSCLC, Other Solid Tumors (RTTNews)
12.10.22	Mirati Therapeutics and Aadi Bioscience Partner to Evaluate the Combination of Adagrasib with Nab-sirolimus in Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors with a KRAS[... (PR Newswire)
04.08.22	VNDA On Watch, NUVA Q2 Results Miss Estimates, MRTX Awaits FDA Decision... (RTTNews)
22.07.22	Pre-market Movers: NCPL, SNAP, HNGR, PDSB, IPI… (RTTNews)
27.05.22	Pre-market Movers: IOVA, MRTX, BIG, GPS, PMVP… (RTTNews)
11.03.22	Pre-market Movers: EXN, ONE, TLYS, IMVT, LAZY… (RTTNews)
22.11.21	Mirati, Verastem To Evaluate Adagrasib, VS-6766 In KRASG12C-Mutant Non-Small Cell Lung Cancer (RTTNews)
20.09.21	Mirati Reports Positive Topline Data From Phase 2 Study With Adagrasib; Names David Meek CEO (RTTNews)
05.08.21	Mirati Therapeutics Reports Second Quarter 2021 Financial Results and Recent Corporate Updates (PR Newswire)
24.06.21	Mirati Therapeutics' Adagrasib Gets Breakthrough Therapy Designation (RTTNews)
24.06.21	Mirati Therapeutics' Adagrasib Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Patients with Advanced Non-Small Cell Lung Cancer Harboring the KRAS G12C Mutation (PR Newswire)
01.06.21	Mirati And Zai Lab Collaborate On Adagrasib In Greater China (RTTNews)
27.10.20	ANAB, GSK Amend Agreement, BSGM Plunges As COVID-19 Trial Flops, CATB Craters, MRTX Abuzz (RTTNews)
18.09.20	Mirati Therapeutics Presents Phase 2 Data On Sitravatinib In Combination With Nivolumab (RTTNews)
22.04.20	LIFE In COVID-19 Battle, LH On Watch, CARA Keeps KALM, All Eyes On MYOV (RTTNews)
11.11.19	LPCN Awaits FDA Word, NKTR On Track, All's Well With Five Prime's FPT155 (RTTNews)
30.10.19	Today's Top 5 Gainers In Healthcare Sector (ISEE, CYCN, STOK…) (RTTNews)
29.10.19	AZN's POSEIDON Has Poise, MRTX On The Move, MOR Drops Atopic Dermatitis Trial (RTTNews)
04.06.19	6 Top Gainers In Pharma Sector (MRTX, NK, GNCA...) (RTTNews)
20.02.19	FDA Nod For NVO's Hemophilia A Drug, ICPT's NASH Trial Hits Goal, NVTA Abuzz (RTTNews)
17.01.19	FDA Panel Nod For Osteoporosis Drug, PTIE Gets Research Funding, ALDR On Watch (RTTNews)
11.01.19	6 Top Gainers In Healthcare Sector (PLXP, AMRN, MRTX...) (RTTNews)
10.11.18	Week Ahead In Pharmaceuticals: 13 Stocks To Watch (EIDX, NOVN, ZYME...) (RTTNews)
06.11.18	AKAO Hits New Low, INSY Shifts Focus From Opioids, FDA Nod For Theratechnologies (RTTNews)
22.10.18	Week Ahead In Pharmaceuticals: 11 Stocks To Watch (MRTX, EPZM, ITCI...) (RTTNews)
04.09.18	Is There Still Room To Run For These Biotech Stocks? (RTTNews)
08.06.18	MRTX Braces For Busy Year, ADXS Stays Focused, OPHT Inks Gene Therapy Deals (RTTNews)
01.06.18	CLSD Dims, SCPH Disappoints, ZEAL On Track, All Eyes On MRTX (RTTNews)
31.05.18	Mirati To Present New Data In Renal Cell Carcinoma From Ongoing Phase 1b Clinical Trial Of Single Agent Sitravatinib At The 2018 ASCO Annual Meeting (PR Newswire)
30.05.18	Mirati Therapeutics To Present At Jefferies 2018 Global Healthcare Conference (PR Newswire)
07.05.18	Mirati Therapeutics Reports First Quarter Financial Results (PR Newswire)
01.05.18	One-Third of College Freshmen Have Less than $1,000 in College Savings; Neither High School nor College Students are Prepared to Manage the Cost of College (PR Newswire)
24.04.18	Mirati Therapeutics Announces Progress Of Lead Programs And Provides Updated Positive Clinical Trial Results For Immuno-Oncology Combination Trials (PR Newswire)
08.03.18	Mirati Therapeutics Reports Fourth Quarter And Full-Year 2017 Financial Results (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	26.99	1.05 %	K V
Swiss Re	129.65	0.89 %	K V
CieFinRichemont	135.90	0.82 %	K V
Zurich Insur Gr	536.60	0.68 %	K V
Roche Hldg G	248.90	0.61 %	K V
Lonza Grp	530.00	-0.19 %	K V
Sonova Hldg	294.90	-0.24 %	K V
Alcon	75.76	-0.34 %	K V
Nestle	73.68	-0.41 %	K V
Geberit	511.00	-0.62 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Mirati Therapeutics Inc

Aktien Top/Flop

Mirati Therapeutics Peer Group Nachrichten

Meistgelesene Nachrichten